FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1118-1124 April 27, 1995 Number 17 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Trials are under way to determine whether fetal nigral grafts can improve motor function in patients with Parkinson's disease. Some studies use fluorodopa uptake on positron-emission tomography (PET) as a marker of graft viability, but fluorodopa uptake does not distinguish between host and grafted neurons. There has been no direct evidence that grafts of fetal tissue can survive and innervate the striatum.

Methods We studied a 59-year-old man with advanced Parkinson's disease who received bilateral grafts of fetal ventral mesencephalic tissue in the postcommissural putamen. The tissue came from seven embryos between 61/2 and 9 weeks after conception. The patient died 18 months later from a massive pulmonary embolism. The brain was studied with the use of tyrosine hydroxylase immunohistochemical methods.

Results After transplantation, the patient had sustained improvement in motor function and a progressive increase in fluorodopa uptake in the putamen on PET scanning. On examination of the brain, each of the large grafts appeared to be viable. Each was integrated into the host striatum and contained dense clusters of dopaminergic neurons. Processes from these neurons had grown out of the grafts and provided extensive dopaminergic reinnervation to the striatum in a patch-matrix pattern. Ungrafted regions of the putamen showed sparse dopaminergic innervation. We could not identify any sprouting of host dopaminergic processes.

Conclusions Grafts of fetal mesencephalic tissue can survive for a long period in the human brain and restore dopaminergic innervation to the striatum in patients with Parkinson's disease. In the patient we studied, clinical improvement and enhanced fluorodopa uptake on PET scanning were associated with the survival of the grafts and dopaminergic reinnervation of the striatum.

Source Information

From the Department of Neurological Sciences, Rush–Presbyterian–St. Luke's Medical Center, Chicago (J.H.K, E.J.M.); the Division of Neurosurgery (T.B.F., P.R.S., D.A.S.) and the Department of Neurology (R.A.H.), University of South Florida, Tampa; the Neurodegenerative Disorders Centre, University of British Columbia, Vancouver (B.J.S., F.J.G.V.); the Tampa Women's Health Center, Tampa, Fla. (G.M.N.); and the Departments of Pathology (D.P.P.) and Neurology (C.W.O.), Mount Sinai Medical Center, New York.

Address reprint requests to Dr. Kordower at the Department of Neurological Sciences, Rush–Presbyterian–St. Luke's Medical Center, 2242 W. Harrison St., Chicago, IL 60612.

Full Text of this Article

Related Letters:

Transplantation of Fetal Mesencephalic Tissue in Parkinson's Disease
Freed C. R., Breeze R. E., Schneck S. A., Kordower J. H., Freeman T. B., Olanow C. W.
Extract | Full Text  
N Engl J Med 1995; 333:730-731, Sep 14, 1995. Correspondence

This article has been cited by other articles:

• Cicchetti, F., Saporta, S., Hauser, R. A., Parent, M., Saint-Pierre, M., Sanberg, P. R., Li, X. J., Parker, J. R., Chu, Y., Mufson, E. J., Kordower, J. H., Freeman, T. B. (2009). Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc. Natl. Acad. Sci. USA 106: 12483-12488 [Abstract] [Full Text]  
• Olanow, C. W., Stern, M. B., Sethi, K. (2009). The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72: S1-S136 [Abstract] [Full Text]  
• Winner, B., Vogt-Weisenhorn, D. M., Lie, C. D., Blumcke, I., Winkler, J. (2009). Review: Cellular repair strategies in Parkinson's disease. Therapeutic Advances in Neurological Disorders 2: 51-60 [Abstract]  
• Walczak, P., Zhang, J., Gilad, A. A., Kedziorek, D. A., Ruiz-Cabello, J., Young, R. G., Pittenger, M. F., van Zijl, P. C.M., Huang, J., Bulte, J. W.M. (2008). Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia. Stroke 39: 1569-1574 [Abstract] [Full Text]  
• Ormerod, B. K, Palmer, T. D, Caldwell, M. A (2008). Neurodegeneration and cell replacement. Phil Trans R Soc B 363: 153-170 [Abstract] [Full Text]  
• Frank, S., Biglan, K. (2007). Long-term fetal cell transplant in Huntington disease: Stayin' alive. Neurology 68: 2055-2056 [Full Text]  
• Breysse, N., Carlsson, T., Winkler, C., Bjorklund, A., Kirik, D. (2007). The Functional Impact of the Intrastriatal Dopamine Neuron Grafts in Parkinsonian Rats Is Reduced with Advancing Disease. J. Neurosci. 27: 5849-5856 [Abstract] [Full Text]  
• Yasuhara, T., Matsukawa, N., Hara, K., Yu, G., Xu, L., Maki, M., Kim, S. U., Borlongan, C. V. (2006). Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson's Disease. J. Neurosci. 26: 12497-12511 [Abstract] [Full Text]  
• Piccini, P., Pavese, N., Hagell, P., Reimer, J., Bjorklund, A., Oertel, W. H., Quinn, N. P., Brooks, D. J., Lindvall, O. (2005). Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 128: 2977-2986 [Abstract] [Full Text]  
• Moreira, T., Palladino, P. (2005). Between truth and hope: on Parkinson's disease, neurotransplantation and the production of the 'self'. History of the Human Sciences 18: 55-82 [Abstract]  
• Mendez, I., Sanchez-Pernaute, R., Cooper, O., Vinuela, A., Ferrari, D., Bjorklund, L., Dagher, A., Isacson, O. (2005). Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128: 1498-1510 [Abstract] [Full Text]  
• Lindvall, O., Kokaia, Z. (2004). Recovery and Rehabilitation in Stroke: Stem Cells. Stroke 35: 2691-2694 [Abstract] [Full Text]  
• Tai, Y F, Piccini, P (2004). Applications of positron emission tomography (PET) in neurology. J. Neurol. Neurosurg. Psychiatry 75: 669-676 [Abstract] [Full Text]  
• McRae, C., Cherin, E., Yamazaki, T. G., Diem, G., Vo, A. H., Russell, D., Ellgring, J. H., Fahn, S., Greene, P., Dillon, S., Winfield, H., Bjugstad, K. B., Freed, C. R. (2004). Effects of Perceived Treatment on Quality of Life and Medical Outcomes in a Double-blind Placebo Surgery Trial. Arch Gen Psychiatry 61: 412-420 [Abstract] [Full Text]  
• Shim, J.-W., Koh, H.-C., Chang, M.-Y., Roh, E., Choi, C.-Y., Oh, Y. J., Son, H., Lee, Y.-S., Studer, L., Lee, S.-H. (2004). Enhanced In Vitro Midbrain Dopamine Neuron Differentiation, Dopaminergic Function, Neurite Outgrowth, and 1-Methyl-4-Phenylpyridium Resistance in Mouse Embryonic Stem Cells Overexpressing Bcl-XL. J. Neurosci. 24: 843-852 [Abstract] [Full Text]  
• Olanow, C. W. (2003). Present and future directions in the management of motor complications in patients with advanced PD. Neurology 61: S24-33 [Full Text]  
• Wechsler, L. R., Kondziolka, D. (2003). Cell Therapy: Replacement. Stroke 34: 2081-2082 [Full Text]  
• Lindvall, O., McKay, R. (2003). Brain repair by cell replacement and regeneration. Proc. Natl. Acad. Sci. USA 100: 7430-7431 [Full Text]  
• Toledo-Aral, J. J., Mendez-Ferrer, S., Pardal, R., Echevarria, M., Lopez-Barneo, J. (2003). Trophic Restoration of the Nigrostriatal Dopaminergic Pathway in Long-Term Carotid Body-Grafted Parkinsonian Rats. J. Neurosci. 23: 141-148 [Abstract] [Full Text]  
• Hochberg, E. P., Miklos, D. B., Neuberg, D., Eichner, D. A., McLaughlin, S. F., Mattes-Ritz, A., Alyea, E. P., Antin, J. H., Soiffer, R. J., Ritz, J. (2003). A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood 101: 363-369 [Abstract] [Full Text]  
• Rosser, A E, Barker, R A, Harrower, T, Watts, C, Farrington, M, Ho, A K, Burnstein, R M, Menon, D K, Gillard, J H, Pickard, J, Dunnett, S B (2002). Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 73: 678-685 [Abstract] [Full Text]  
• Redmond, D. E. Jr. (2002). Book Review: Cellular Replacement Therapy for Parkinson's Disease--Where We Are Today?. Neuroscientist 8: 457-488 [Abstract]  
• Hauser, R. A., Furtado, S., Cimino, C. R., Delgado, H., Eichler, S., Schwartz, S., Scott, D., Nauert, G. M., Soety, E., Sossi, V., Holt, D. A., Sanberg, P. R., Stoessl, A. J., Freeman, T. B. (2002). Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58: 687-695 [Abstract] [Full Text]  
• Clark, P. A. (2002). Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?. J Law Med Ethics 30: 58-68  
• Freed, C. R. (2002). Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?. Proc. Natl. Acad. Sci. USA 99: 1755-1757 [Full Text]  
• Sondhi, D., Hackett, N. R., Apblett, R. L., Kaminsky, S. M., Pergolizzi, R. G., Crystal, R. G. (2001). Feasibility of Gene Therapy for Late Neuronal Ceroid Lipofuscinosis. Arch Neurol 58: 1793-1798 [Abstract] [Full Text]  
• Chen, J., Sanberg, P. R., Li, Y., Wang, L., Lu, M., Willing, A. E., Sanchez-Ramos, J., Chopp, M. (2001). Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in Rats. Stroke 32: 2682-2688 [Abstract] [Full Text]  
• Olanow, C. W., Freeman, T., Kordower, J., Redmond, D. E. Jr., Sladek, J. R., Spencer, D. D., Freed, C. R., Breeze, R. E., Fahn, S. (2001). Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease. NEJM 345: 146-147 [Full Text]  
• Olanow, C. W., Watts, R. L., Koller, W. C. (2001). An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment. Neurology 56: S1-S88 [Full Text]  
• Mukhida, K., Baker, K. A., Sadi, D., Mendez, I. (2001). Enhancement of Sensorimotor Behavioral Recovery in Hemiparkinsonian Rats with Intrastriatal, Intranigral, and Intrasubthalamic Nucleus Dopaminergic Transplants. J. Neurosci. 21: 3521-3530 [Abstract] [Full Text]  
• Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., Eidelberg, D., Fahn, S. (2001). Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease. NEJM 344: 710-719 [Abstract] [Full Text]  
• Beal, M. F., Hantraye, P. (2001). Novel therapies in the search for a cure for Huntington's disease. Proc. Natl. Acad. Sci. USA 98: 3-4 [Full Text]  
• Freeman, T. B., Cicchetti, F., Hauser, R. A., Deacon, T. W., Li, X.-J., Hersch, S. M., Nauert, G. M., Sanberg, P. R., Kordower, J. H., Saporta, S., Isacson, O. (2000). Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology. Proc. Natl. Acad. Sci. USA 97: 13877-13882 [Abstract] [Full Text]  
• Azizi, S. A. (2000). Exploiting Nonneural Cells to Rebuild the Nervous System: From Bone Marrow to Brain. Neuroscientist 6: 353-361 [Abstract]  
• Lang, A. E. (2000). Surgery for Parkinson Disease: A Critical Evaluation of the State of the Art. Arch Neurol 57: 1118-1125 [Full Text]  
• Lee, C. S., Cenci, M. A., Schulzer, M., Bjorklund, A. (2000). Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 123: 1365-1379 [Abstract] [Full Text]  
• Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Bjorklund, A., Brooks, D. J., David Marsden, C., Oertel, W. H., Quinn, N. P., Rehncrona, S., Lindvall, O. (2000). Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123: 1380-1390 [Abstract] [Full Text]  
• Schumacher, J. M., Ellias, S. A., Palmer, E. P., Kott, H. S., Dinsmore, J., Dempsey, P. K., Fischman, A. J., Thomas, C., Feldman, R. G., Kassissieh, S., Raineri, R., Manhart, C., Penney, D., Fink, J. S., Isacson, O. (2000). Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54: 1042-1050 [Abstract] [Full Text]  
• Bulte, J. W. M., Zhang, S.-C., van Gelderen, P., Herynek, V., Jordan, E. K., Duncan, I. D., Frank, J. A. (1999). Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 96: 15256-15261 [Abstract] [Full Text]  
• Hallett, M., Litvan, I. (1999). Evaluation of surgery for Parkinson's disease: A Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 53: 1910-1910 [Full Text]  
• Freeman, T. B., Vawter, D. E., Leaverton, P. E., Godbold, J. H., Hauser, R. A., Goetz, C. G., Olanow, C. W. (1999). Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease. NEJM 341: 988-992 [Full Text]  
• Collier, T. J., Sortwell, C. E., Daley, B. F. (1999). Diminished Viability, Growth, and Behavioral Efficacy of Fetal Dopamine Neuron Grafts in Aging Rats with Long-Term Dopamine Depletion: An Argument for Neurotrophic Supplementation. J. Neurosci. 19: 5563-5573 [Abstract] [Full Text]  
• Hagell, P., Schrag, A., Piccini, P., Jahanshahi, M., Brown, R., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Odin, P., Wenning, G. K., Morrish, P., Gustavii, B., Bjorklund, A., Brooks, D. J., Marsden, C. D., Quinn, N. P., Lindvall1, O. (1999). Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft. Brain 122: 1121-1132 [Abstract] [Full Text]  
• Mahoney, M. J., Saltzman, W. M. (1999). Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. Proc. Natl. Acad. Sci. USA 96: 4536-4539 [Abstract] [Full Text]  
• Hauser, R. A., Freeman, T. B., Snow, B. J., Nauert, M., Gauger, L., Kordower, J. H., Olanow, C. W. (1999). Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease. Arch Neurol 56: 179-187 [Abstract] [Full Text]  
• ROSSINI, A. A., GREINER, D. L., MORDES, J. P. (1999). Induction of Immunologic Tolerance for Transplantation. Physiol. Rev. 79: 99-141 [Abstract] [Full Text]  
• Lang, A. E., Lozano, A. M. (1998). Parkinson's Disease- Second of Two Parts. NEJM 339: 1130-1143 [Full Text]  
• Mandel, R. J., Rendahl, K. G., Spratt, S. K., Snyder, R. O., Cohen, L. K., Leff, S. E. (1998). Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson's Disease. J. Neurosci. 18: 4271-4284 [Abstract] [Full Text]  
• Azizi, S. A., Stokes, D., Augelli, B. J., DiGirolamo, C., Prockop, D. J. (1998). Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats---similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA 95: 3908-3913 [Abstract] [Full Text]  
• Lang, A. E., Lozano, A. M., Montgomery, E., Duff, J., Tasker, R., Hutchinson, W. (1997). Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease. NEJM 337: 1036-1043 [Abstract] [Full Text]  
• McKay, R. (1997). Stem Cells in the Central Nervous System. Science 276: 66-71 [Abstract] [Full Text]  
• White, R. J. (1996). A 61-Year-Old Man With Parkinson's Disease. JAMA 276: 104-104 [Abstract]  
• Olanow, C. W. (1996). A 61-Year-Old Man With Parkinson's Disease. JAMA 275: 716-722 [Abstract]  
• Freed, C. R., Breeze, R. E., Schneck, S. A., Kordower, J. H., Freeman, T. B., Olanow, C. W. (1995). Transplantation of Fetal Mesencephalic Tissue in Parkinson's Disease. NEJM 333: 730-731 [Full Text]  
• Hoffer, B. J., van Horne, C. (1995). Survival of Dopaminergic Neurons in Fetal-Tissue Grafts. NEJM 332: 1163-1164 [Full Text]  
• Sawamoto, K., Nakao, N., Kobayashi, K., Matsushita, N., Takahashi, H., Kakishita, K., Yamamoto, A., Yoshizaki, T., Terashima, T., Murakami, F., Itakura, T., Okano, H. (2001). Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc. Natl. Acad. Sci. USA 98: 6423-6428 [Abstract] [Full Text]